Digital Therapeutics - United States

United States

Highlights

Revenue in the Digital Therapeutics market is projected to reach US$3.15k in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1,735.00%, resulting in a projected market volume of US$6.54bn by 2029.
User penetration will be 22.91% in 2024 and is expected to hit 44.30% by 2029.
The average revenue per user (ARPU) is expected to amount to US$0.00.
In global comparison, most revenue will be generated United States (US$3.15k in 2024).

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digital Therapeutics market in United States is experiencing significant growth and development.

Customer preferences: Customers in the United States are increasingly seeking out digital therapeutics solutions for managing various health conditions such as diabetes, mental health disorders, cardiovascular issues, and musculoskeletal problems. The convenience, accessibility, and personalized nature of these digital tools appeal to tech-savvy consumers looking for innovative ways to improve their health outcomes.

Trends in the market: One prominent trend in the Digital Therapeutics market in the United States is the integration of artificial intelligence and machine learning algorithms into digital health platforms. These technologies enable more precise monitoring of health metrics, personalized treatment recommendations, and predictive analytics to anticipate health issues before they arise. Additionally, there is a growing emphasis on data security and privacy compliance to meet the stringent regulations in the healthcare industry.

Local special circumstances: The United States has a well-established healthcare system with a strong focus on innovation and technology adoption. This environment fosters the growth of the Digital Therapeutics market as healthcare providers, insurers, and consumers are open to incorporating digital solutions into traditional care pathways. Moreover, the presence of leading tech companies and research institutions in the country drives collaboration and investment in digital health technologies.

Underlying macroeconomic factors: The increasing prevalence of chronic diseases, rising healthcare costs, and the shift towards value-based care models are key macroeconomic factors driving the demand for Digital Therapeutics in the United States. As healthcare stakeholders look for cost-effective ways to deliver quality care and improve patient outcomes, digital therapeutics offer a scalable and sustainable solution. Furthermore, government initiatives and reimbursement policies supporting telehealth and remote patient monitoring contribute to the growth of the digital health sector in the country.

Data coverage:

The data encompasses B2C enterprises. Figures are based on revenues and user data of relevant mobile applications and consumer electronics companies.

Modeling approach / Market size:

Market sizes are determined through a combined top-down and bottom-up approach, building on a specific rationale for each market segment. As a basis for evaluating markets, we use annual financial reports of key players, industry reports, third-party reports, and survey results from primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, population, internet penetration, smartphone penetration, consumer spending, and healthcare spending. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting digital products and services due to the non-linear growth of technology adoption.

Additional notes:

The market is updated twice a year in case market dynamics change. The impact of the COVID-19 pandemic and the Russia-Ukraine war is considered at a country-specific level.